Schedule 13G ownership disclosure

Cancer Genetics Inc

Security class unavailable · CUSIP: 13739U203

Event date: 2020-11-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
250,000
Percent of class
6.4600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-20-000345
Form type
SC 13G
Filer
Vyant Bio, Inc.
CIK
CIK 1349929
Filed
Nov 02, 2020
Reporting period
Nov 02, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub